일본의 3D 바이오프린팅 시장 보고서 : 컴포넌트, 용도, 최종사용자, 지역별(2025-2033년)
Japan 3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2025-2033
상품코드:1609861
리서치사:IMARC
발행일:On Demand Report
페이지 정보:영문 122 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
일본의 3D 바이오프린팅 시장의 시장 규모는 2024년에 8,290만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 3억 1,670만 달러에 달하며, 2025-2033년 16.1%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 노년 인구에서 장기 이식 요구의 증가와 의료 기술에 대한 용이한 액세스가 주로 시장 성장의 원동력이 되고 있습니다.
본 리포트에서 답변하는 주요 질문
일본의 3D 바이오프린팅 시장은 지금까지 어떻게 추이해 왔으며, 향후 어떻게 추이하는가?
일본의 3D 바이오프린팅 시장에 COVID-19가 미친 영향은?
일본의 3D 바이오프린팅 시장의 컴포넌트별 내역은?
일본의 3D 바이오프린팅 시장의 용도별 내역은?
일본의 3D 바이오프린팅 시장의 최종사용자별 내역은?
일본의 3D 바이오프린팅 시장의 밸류체인에는 어떤 단계가 있는가?
일본의 3D 바이오프린팅에서 주요 촉진요인과 과제는?
일본의 3D 바이오프린팅 시장의 구조와 주요 기업은?
일본의 3D 바이오프린팅 시장에서 경쟁의 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
조사의 목적
이해관계자
데이터 소스
시장 추정
조사 방법
제3장 개요
제4장 일본의 3D 바이오프린팅 시장 : 서론
개요
시장 역학
업계 동향
경쟁 정보
제5장 일본의 3D 바이오프린팅 시장 구도
과거 및 현재 시장 동향(2019-2024년)
시장 예측(2025-2033)
제6장 일본의 3D 바이오프린팅 시장 : 컴포넌트별 내역
3D 바이오프린터
스캐폴드
생체 재료
제7장 일본의 3D 바이오프린팅 시장 : 용도별 내역
연구
임상
제8장 일본의 3D 바이오프린팅 시장 : 최종사용자별 내역
병원
연구기관 및 학술기관
바이오의약품 기업
제8장 일본의 3D 바이오프린팅 시장 : 경쟁 구도
개요
시장 구조
시장 기업 포지셔닝
주요 성공 전략
경쟁 대시보드
기업 평가 상한
제9장 주요 기업의 개요
제10장 일본의 3D 바이오프린팅 시장 : 업계 분석
촉진요인·억제요인·기회
Porter's Five Forces 분석
밸류체인 분석
제11장 부록
KSA
영문 목차
영문목차
Japan 3D bioprinting market size reached USD 82.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% during 2025-2033. The elevating need for organ transplantation among the geriatric population, along with the easy access to medical technologies, is primarily driving the market growth.
Three-dimensional (3D) bioprinting is an additive manufacturing technique developed for the precise fabrication of anatomical tissues. This method encompasses various deposition and assembly processes, including direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. In addition to this, it relies on the layer-by-layer assembly of cell-based bio-inks, which are formulated using living cells, biomaterials, and active biomolecules, to construct 3D tissue and organ structures. By depositing multiple layers of biomaterials, 3D bioprinting can create complex bodily structures such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. Consequently, it finds extensive applications in hospitals, research institutions, academic establishments, and biopharmaceutical companies across Japan.
Japan 3D Bioprinting Market Trends:
In the context of the Japan market, the increasing emphasis on reducing animal testing is a significant factor positively influencing the industry. Additionally, the rising demand for 3D bioprinting, particularly among the elderly population who are more susceptible to various chronic illnesses, is fostering a favorable market outlook, thereby acting as another significant growth-inducing factor. Besides this, technological advancements such as the development of organ-on-a-chip systems are also driving market growth. Furthermore, the surging global demand for regenerative medicines, cancer therapeutics, and stem cell solutions is contributing to the expansion of the market. Apart from this, the healthcare sector in Japan is increasingly adopting 3D bioprinting, and its relatively lower disruption level compared to other industries is providing substantial support to market growth. Moreover, prominent manufacturers are placing a strong focus on research and development (R&D) activities aimed at introducing bio printed tissues, which is positively influencing the regional market. This effort aims to reduce the cost associated with new innovations and streamline the drug discovery process, further propelling advancement within Japan. All these above mentioned factors are expected to catalyze the market growth over the forecasted period.
Japan 3D Bioprinting Market Segmentation:
Component Insights:
3D Bioprinters
Syringe/Extrusion Bioprinting
Inkjet Bioprinting
Magnetic Levitation Bioprinting
Laser-assisted Bioprinting
Others
Scaffolds
Biomaterials
Living Cells
Hydrogels
Extracellular Matrices
Others
Application Insights:
Research
Drug Research
Regenerative Medicine
3D Cell Culture
Clinical
Skin
Bone and Cartilage
Blood Vessels
Others
End User Insights:
Hospitals
Research Organization and Academic Institutes
Biopharmaceuticals Companies
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
How has the Japan 3D bioprinting market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan 3D bioprinting market?
What is the breakup of the Japan 3D bioprinting market on the basis of component?
What is the breakup of the Japan 3D bioprinting market on the basis of application?
What is the breakup of the Japan 3D bioprinting market on the basis of end user?
What are the various stages in the value chain of the Japan 3D bioprinting market?
What are the key driving factors and challenges in the Japan 3D bioprinting?
What is the structure of the Japan 3D bioprinting market and who are the key players?
What is the degree of competition in the Japan 3D Bioprinting market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan 3D Bioprinting Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan 3D Bioprinting Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Japan 3D Bioprinting Market - Breakup by Component
6.1 3D Bioprinters
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.3.1 Syringe/Extrusion Bioprinting
6.1.3.2 Inkjet Bioprinting
6.1.3.3 Magnetic Levitation Bioprinting
6.1.3.4 Laser-assisted Bioprinting
6.1.3.5 Others
6.1.4 Market Forecast (2025-2033)
6.2 Scaffolds
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Forecast (2025-2033)
6.3 Biomaterials
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.3.1 Living Cells
6.3.3.2 Hydrogels
6.3.3.3 Extracellular Matrices
6.3.3.4 Others
6.3.4 Market Forecast (2025-2033)
7 Japan 3D Bioprinting Market - Breakup by Application
7.1 Research
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.3.1 Drug Research
7.1.3.2 Regenerative Medicine
7.1.3.3 3D Cell Culture
7.1.4 Market Forecast (2025-2033)
7.2 Clinical
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.3.1 Skin
7.2.3.2 Bone and Cartilage
7.2.3.3 Blood Vessels
7.2.3.4 Others
7.2.4 Market Forecast (2025-2033)
8 Japan 3D Bioprinting Market - Breakup by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Forecast (2025-2033)
8.2 Research Organization and Academic Institutes
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Forecast (2025-2033)
8.3 Biopharmaceuticals Companies
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Forecast (2025-2033)
8 Japan 3D Bioprinting Market - Competitive Landscape
8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant
9 Profiles of Key Players
9.1 Company A
9.1.1 Business Overview
9.1.2 Product Portfolio
9.1.3 Business Strategies
9.1.4 SWOT Analysis
9.1.5 Major News and Events
9.2 Company B
9.2.1 Business Overview
9.2.2 Product Portfolio
9.2.3 Business Strategies
9.2.4 SWOT Analysis
9.2.5 Major News and Events
9.3 Company C
9.3.1 Business Overview
9.3.2 Product Portfolio
9.3.3 Business Strategies
9.3.4 SWOT Analysis
9.3.5 Major News and Events
9.4 Company D
9.4.1 Business Overview
9.4.2 Product Portfolio
9.4.3 Business Strategies
9.4.4 SWOT Analysis
9.4.5 Major News and Events
9.5 Company E
9.5.1 Business Overview
9.5.2 Product Portfolio
9.5.3 Business Strategies
9.5.4 SWOT Analysis
9.5.5 Major News and Events
10 Japan 3D Bioprinting Market - Industry Analysis
